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BiopsyAbstract Objective: We aimed to evaluate CT guided biopsy (CTGB) vs. standard closed pleural
biopsy (CPB) in the histopathological diagnosis of the type of malignancy in patients with
malignant pleural effusion.
Patients and methods: We studied 31 patients (21 male and 10 female) with malignant pleural
effusion diagnosed by aspiration cytology and admitted to the medical ward of a general teaching
hospital over a period of 1 year. Patients were randomized into two groups: group 1 (n= 16)
underwent CTGB biopsy and group 2 (n= 15) underwent Abram’s CPB. The diagnostic yield of
both methods was compared.
Results: The mean age of patients was 54 ± 16 years. History of smoking was obtained in 15
(48.4%) patients. Dyspnea was reported in 22 (71%) and chest pain in 15 (48.4%). Malignant
pleural effusion was left-sided in 17 (54.8%), and massive in 21 (67.7%) patients. Of note, CT
imaging revealed parietal pleura as a tumor site in 20 (64.5%) patients. Pathological diagnosis of
the type of malignancy was achieved in 14 (87.5%) of group 1 using CTGB and 6 (40%) of group
2 patients using Abram’s CPB. The diagnostic value of CTGB was signiﬁcantly higher than CPB
(P= 0.009).
Conclusion: CT-guided biopsy was found to be a reliable and safe method in the histopatholo-
gical diagnosis of malignant pleural effusion. Its diagnostic potential was much superior to the
standard closed pleural biopsy.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of The Egyptian Society of Chest
Diseases and Tuberculosis. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Pleural disease may present as focal pleural nodules or diffuse
pleural thickening and could be due to benign or malignant
etiologies. Effusion is frequently an early sign of pleuralrculosis.
406 N.A.S.A. Rezk et al.disease, and pleural ﬂuid cytology is accepted as the ﬁrst diag-
nostic test in the evaluation of unilateral pleural effusion [1].
Malignant pleural effusion (MPE) is a common complica-
tion and sometimes the initial manifestation of underlying
intrathoracic, extrathoracic or far-advanced malignancies.
Common cancer types causing MPEs include lymphomas,
mesotheliomas, and carcinomas of the breast, lung, gastroin-
testinal tract, and ovaries. However, almost all tumor types
have been reported to cause MPEs. The median survival after
diagnosis of MPE is 4 months [2].
Standard pleural ﬂuid cytology is a simple, safe and mini-
mally invasive method to diagnose pleural malignancy. It
could help to characterize up to 60% of malignant effusions
[1]. However, in malignant mesothelioma, it is diagnostic in
as low as 30% of cases [3]. Noteworthy, cytological evaluation
of the pleural effusion has besides problems with sensitivity,
difﬁculties with speciﬁcity because of limitations in differenti-
ating between different types of cancer like adenocarcinoma,
mesothelioma, lymphoma and non-malignant reactive lym-
phocytosis. Additional tests like assay of pleural ﬂuid for
tumor markers might improve the diagnostic yield of cytology.
The diagnostic value of tumor markers for MPE, however,
remains limited, with no single marker being sufﬁciently sensi-
tive or speciﬁc to be introduced into routine practice [4].
Moreover, pleural ﬂuid cytology sometimes fails to subclassify
the malignant cell types, which is essential for further manage-
ment of chemosensitive malignancies [5].
Pleural biopsy is still an important diagnostic tool in fur-
ther characterizing the nature of pleural disease. Nonsurgical,
percutaneous pleural biopsy in patients with pleural effusion
was ﬁrst described in the 1950s by Abrams and Cope [6,7]. This
biopsy procedure can be performed at bedside, without any
imaging for guidance. The use of the Abrams pleural biopsy
needle has a sensitivity of up to 90% for the diagnosis of tuber-
culosis [8,9]. This high sensitivity rate is thought to be due to
the diffuse nature of pleural involvement by tuberculosis, as
opposed to the more patchy distribution demonstrated in
malignant disease.
In malignant effusion, the diagnostic yield of blind pleural
biopsy using Abrams or Cope needle is between 48% and
56%. The sensitivity for diagnosis of malignant mesothelioma
is only 21–43%. Furthermore, the absence of pleural effusion
precludes the safe deployment and use of these needles.
Complications are encountered in up to 9.3% of patients
and may include pneumothorax, hemothorax and vasovagal
reaction [9].
Recently, image-guided biopsy of focal pleural nodules or
diffuse pleural thickening has been advocated as the preferred
method for diagnosis of both benign and malignant pleural
diseases. It has a greater sensitivity for the diagnosis of malig-
nant diseases compared with the Abrams biopsy and has been
shown to be accurate in diagnosing malignant pleural mesothe-
lioma [10]. Using CT or ultrasound (US) guidance, image-
guided percutaneous biopsy allows a focal area of pleural
abnormality to be sampled. Both CT and US can be used to
localize the most suspicious area within the pleura, but the ﬁeld
of view for US is more limited than that of CT. Cutting needle
biopsy is preferred over ﬁne needle aspiration (FNA) because
it has a higher sensitivity in the diagnosis of malignant pleural
disease [10].
We aimed to assess the diagnostic yield of CT-guided
pleural biopsy using a semi-automated biopsy gun versus theclassic Abrams closed pleural biopsy in patients with malig-
nant pleural effusion.
Patients and methods
We included 31 consecutive adult patients (age >18 years)
with cytology-positive malignant pleural effusion. Patients
were admitted to the department of Chest Medicine between
May 2012 and June 2013. Patients with evidence of bleeding
disorders were excluded from the study. All patients were sub-
jected to the following: full history taking, thorough clinical
examination, routine blood investigation, chest X-ray, and
chest CT scan. Patients were randomized into two groups:
group 1 (n= 16, 10 male and 6 female) underwent CT guided
biopsy (CTGB) and group 2 (n= 15, 11 male and 4 female)
underwent closed pleural biopsy (CPB). Conﬁrmation of
malignancy by pleural ﬂuid cytology was a prerequisite prior
to either closed pleural biopsy by Abrams needle or CTGB
by semi-automated biopsy gun 16 French. All included
patients accepted the procedure by written consent.
Cytology
Fifty milliliter sample aspirated from pleural ﬂuid was sent for
cytological exanimation. If the ﬁrst sample was negative for
malignant cells, a second sample was obtained which if also
deemed negative a third sample in sequence was taken to
conﬁrm or rule out malignancy. The ﬂuid was stained with
Papanicolaou stain and hematoxylin eosin stain. The stained
smear was then examined for the presence of malignant cell.
Closed pleural biopsy technique
Patients were given 1% lidocaine as local anesthetic. A small
incision was made by a surgical blade. The reverse-beveled
pleural biopsy needle (Abrams needle) was advanced into the
pleural space as conﬁrmed by free ﬂow of ﬂuid while aspirating
and pulled back to ‘‘hook’’ the pleura to collect a biopsy
sample. Four to six passes were usually required to obtain
an adequate diagnostic specimen as described previously
[8,11]. The tissue specimens were examined by an experienced
pulmonary pathologist. The main contraindications for this
procedure were INR> 2 or low platelets’ count <50,000 [12].
Technique of CT guided pleural biopsy [13]
Intravenous access, continuous pulse oximetry and vital
monitoring were established prior to the procedure. Patient’s
position depended on the site of the lesion. Patients were asked
to take small inspirations so that there would be minimal
motion once the needle has passed through the pleura. This
is because deeper inspirations might cause signiﬁcant needle
movement with greater chances of tearing the pleural surface.
The grid superimposition technique was used. The skin entry
site was marked using a measuring scale and laser light in
correspondence to midline. After cleansing the area, a small
plastic marker or hypodermic needle was placed on the skin
mark and a scan was obtained at that level for conﬁrmation.
Next, a local anesthetic (1–2% lignocaine) was injected. All
the needle manipulations were performed with the patient in
Figure 2 A 53-year old patient with mesothelioma.
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biopsy needle parallel to the pleural thickening was applied.
Then we introduced the automated biopsy gun to the lesion
and pressed on its top to take a biopsy. We obtained small lin-
ear tissue sections suitable for histological evaluation using the
automated core needle. We withdrew the biopsy gun during
breathing holding maneuver. The specimen was sent for histo-
pathological analysis in a formalin solution. Fig. 1 and Fig. 2
show the CT image of chondrosarcoma and mesothelioma in
two of study patients.
Statistical analysis
IBM SPSS statistics version 21 (IBM SPSS New York,
U.S.A) was used to analyze the data. Categorical variables
were expressed as numbers and percentages and continuous
variables as mean ± standard deviation. Fisher exact test
was used to detect signiﬁcant difference between categorical
variables in CPB and CTGB groups. Differences in means
were compared using independent samples t-test. A P-value
of <0.05 was considered statistically signiﬁcant.
Results
Of 31 patients with MPE, group1 included 10 male and 6
female (mean age, 48 years) while group 2 included 11 male
and 4 female (mean age, 60 years). There was a signiﬁcant dif-
ference in age between the two groups (P= 0.031). History of
smoking was obtained in 15 (48.4%) patients. Dyspnea was
reported in 22 (71%) and chest pain 15 (48.4%). Table 1 shows
the demographic characteristics of the study patients. Malig-
nant pleural effusion was left-sided in 17 (54.8%), and massive
in 21 (67.7%) patients. Of note, CT imaging revealed parietal
pleura as a tumor site in 20 (64.5%) patients. Interestingly,
pathological diagnosis was signiﬁcantly achieved in group 1
by the use of CTGB in 14 (87.5%) vs. 6 (40%) in group 2 using
CPB (P= 0.009). Post-CTGB complications included bleed-
ing 2 (12.5%) and pneumothorax 2 (12.5%). Similarly, after
CPB, 2 (13.3%) patients had bleeding and 1 (6.7%) had pneu-
mothorax. Complications were minimal and treated by conser-
vative therapy. Table 2 displays the main radiological ﬁndings,
laboratory investigation, and biopsy-related complications.
Computed tomography showed single mass in 9 (29%),Figure 1 A 20-year old patient with chondrosarcoma.multiple masses 6 (19.4%), nodules 8 (25.8%) and pleural
thickening 8 (25.8%) as presented in Table 3. Pathological
diagnosis was not reached by CTGB in 2 (12.5%) of group 1
patients. These 2 patients later underwent thoracoscopy which
uncovered the diagnosis of the tumor type. In group 2,
however, 9 (60%) could not be diagnosed by CPB; they all
underwent CTGB where 7 were diagnosed by CTGB and 2
subsequently diagnosed via thoracoscopy. Table 4 shows the
pathological diagnosis of tumor type in patients with malig-
nant pleural effusion.
Discussion
Routine investigation of pleural ﬂuid and pleural biopsy
remains the best method of diagnosis of the nature of the pleu-
ral ﬂuid [12]. The value of blind biopsy in diagnosing malig-
nant effusion is controversial due to low diagnostic
sensitivity particularly when compared with image-guided
and thoracoscopic pleural biopsies [14]. In our study the diag-
nostic yield of Abrams closed needle biopsy was somewhat
similar to the study of Bhattacharya and coworkers [15] on
66 patients with malignant pleural effusion who underwent
closed pleural biopsy and diagnosed 48% as a malignant. This
relatively low yield of blind pleural biopsy was attributed to
the sparse, variable and uneven distribution of the tumor
invading the pleura.
In one review, analysis of diagnostic yield of pleural biopsy
for malignancy was 57% [16]. However, the yield varied
between 40% and 75% [17–21]. In another study with Tru
cut needle biopsy, it reached 85.7% [5]. In case of malignant
mesotheliomas, the diagnostic yield is even lower. Attanoos
and Gibbs [22] conducted a review of 45 cases postmortem
in which 91% had had the same antemortem diagnosis. For
deﬁnitive diagnosis closed blind pleural biopsies yielded sensi-
tivity at as low as 16% and high speciﬁcity at 94%.
Features of contrast-enhanced CT scanning that favors the
diagnosis of malignant disease rather than benign disease
include nodular, mediastinal, or circumferential pleural thick-
ening or parietal pleural thickening >1 cm [23]. In our study,
chest CT scan with contrast-enhancement showed single mass,
multiple masses, nodules and pleural thickening. The diagnos-
tic yield of CTGB was signiﬁcantly higher than CPB with min-
imal complications. In an earlier study, Maskell et al. [14]
compared the sensitivity of contrast-enhanced CT-guided
Table 1 Demographic characteristics and major symptoms of patients with malignant pleural effusion.
Group 1 Group 2 P value All patients
CTGB CPB
(N= 16) (N= 15)
Age (years), mean ± SD 48 ± 17 60 ± 12 0.031 54 ± 16
Gender, male, no. (%) 10 (62.5) 11 (73.3) 0.704 21 (67.7)
Smoking, no. (%) 9 (56.3) 6 (40) 0.479 15 (48.4)
Chest pain, no. (%) 6 (37.5) 9 (60) 0.210 15 (48.4)
Dyspnea, no. (%) 12 (75) 10 (66.7) 0.704 22 (71.0)
Table 2 Main radiological ﬁndings, laboratory investigation, and biopsy-related complications in patients with malignant pleural
effusion.
Group 1 Group 2 P value All patients
(CTGB) (CPB)
CXR eﬀusion, left, no. (%) 9 (56.3) 8 (53.3) 0.870 17 (54.8)
Massive eﬀusion, no. (%) 12 (75) 9 (60) 0.458 21 (67.7)
Site of tumor by CT, parietal pleura, no. (%) 9 (56.3) 11 (73.3) 0.320 20 (64.5)
Platelets count, mean ± SD (·103) 276.9 ± 79.5 244.7 ± 59.2 0.213 261.3 ± 71.2
RBCs count, mean ± SD (·106) 3.77 ± 1.2 4.09 ± 1.2 0.457 3.92 ± 1.19
LDH, mean ± SD 563.8 ± 247.9 489.3 ± 232.9 0.397 527.7 ± 239.7
pH, mean ± SD 7.025 ± 0.284 7.047 ± 0.207 0.811 7.035 ± 0.246
Biopsy diagnosis of malignancy type, no. (%) 14 (87.5) 6 (40) 0.009 20 (64.5)
Post procedure bleeding, no. (%) 2 (12.5) 2 (13.3) 1 4 (12.9)
Post procedure pneumothorax, no. (%) 2 (12.5) 1 (6.7) 1 3 (9.7)
Table 3 CT ﬁndings in patients with malignant pleural
effusion.
Group 1 Group 2 Total
(CTGB) N (%) (CPB) N (%) N (%)
Single mass 5 (31.3) 4 (26.6) 9 (29.0)
Multiple masses 4 (25) 2 (13.4) 6 (19.4)
Nodules 4 (25) 4 (26.6) 8 (25.8)
Pleural thickening 3 (18.7) 5 (33.4) 8 (25.8)
Table 4 Final pathological diagnosis of tumor type in patients wit
Tumor pathology Group 1
CTGB (n= 16)
Achieved by
CTGB
Required alte
procedure
Adenocarcinoma of
lung
5 1*
Mesothelioma 3 –
Metastatic
adenocarcinoma
3 –
Lymphoma
Chondrosarcoma
1 1*
Large cell carcinoma 1 –
1 –
Total 14 2
* Pathological diagnosis achieved by thoracoscopy.
# Pathological diagnosis achieved in two cases by thoracoscopy and in
$ Pathological diagnosis achieved by CTGB.
408 N.A.S.A. Rezk et al.biopsy vs. Abrams blind biopsy among cytology-negative
patients with suspected malignant pleural effusion. They found
that the CT guided-biopsy had 87% sensitivity vs. 47% in
Abrams’ biopsy. Although both procedures had 100% speciﬁc-
ity and positive predictive value, the negative predictive value
of CT-guided biopsy was higher at 80% compared with 44%
with Abram’s needle.
To compare the diagnostic sensitivity and complications of
CT-guided biopsy with that of thoracoscopy, Metintas et al.
[24] studied 124 patients with exudative pleural effusion thath malignant pleural effusion.
Group 2 Total N
(%)CPB group (n= 15)
rnate Achieved by
CPB
Required alternate
procedure
3 6# 15 (48.4)
1 1$ 5 (16.1)
0 2$ 5 (16.1)
2 – 4 (12.9)
0 – 1 (3.2)
0 – 1 (3.2)
6 9 31 (100)
four cases by CTGB.
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tors randomized the patients after a CT scan. Patients under-
went either CT-guided biopsy using Abrams needle or
thoracoscopy. The authors concluded that in the CT-Abram
needle pleural biopsy group, the diagnostic sensitivity was
87.5% vs. 94.1% in the thoracoscopy group; the difference
was not statistically signiﬁcant and complication rates were rel-
atively low.
Likewise, Adams et al. [10] found that CT-cutting needle
biopsy had 86% sensitivity and 100% speciﬁcity in achieving
the correct histological diagnosis of malignant mesothelioma.
The complications were also minimal. In another study, Bena-
more et al. [25] reported pleural biopsies under CT guidance
had 76% sensitivity and 100% speciﬁcity. The researchers
reported no major complications. Nevertheless, pneumothorax
was detected by chest radiography in 4.7% of patients, but
none required a pneumothorax evacuation tube.
The limitation of this study was that only 31 cases were
studied. However, this was a preliminary study and the results
related to CT guided biopsy were reasonably encouraging.
In conclusion, despite the closed pleural biopsy is widely
available, easy to perform, and can be performed on outpa-
tient basis, its diagnostic yield was low. CT-guided biopsy
was a reliable and safe method in the diagnosis of malignant
pleural effusion. The diagnostic accuracy was much superior
to the standard closed pleural biopsy. Both techniques had
minimal procedure-related complications.
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